AbolerIS Pharma Revenue

Biotechnology Research • Charleroi, Walloon Region, Belgium • 11-20 Employees

AbolerIS Pharma revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$77,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,200,000
Total funding	$29,200,000

Key Contact at AbolerIS Pharma

Jannie Ausma

Director Clinical Operations

Company overview

Headquarters	Charleroi, Walloon Region, Belgium
Website	aboleris-pharma.com
NAICS	541714
Founded	2019
Employees	11-20
Socials

AbolerIS Pharma Email Formats

AbolerIS Pharma uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@aboleris-pharma.com), used 54.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@aboleris-pharma.com	54.5%
{first initial}.{last name}	j.doe@aboleris-pharma.com	45.5%

About AbolerIS Pharma

Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Head

C-Suite

Employees by Department

AbolerIS Pharma has 3 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore AbolerIS Pharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-10-18	4	$29,200,000

Funding Insights

$29,200,000

Total funding amount

$29,200,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

AbolerIS Pharma is located in Charleroi, Walloon Region, BE.

AbolerIS Pharma generates an estimated annual revenue of $1,000,000. This revenue figure reflects the company's market position and business performance in its industry.

AbolerIS Pharma has an estimated valuation of $3,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

AbolerIS Pharma was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

AbolerIS Pharma has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

AbolerIS Pharma has raised a total of $29,200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at AbolerIS Pharma

Jannie Ausma

Director Clinical Operations

4.8

40,000 users